# OnCo record carnitine-acetyl-l-carnitine (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/carnitine-acetyl-l-carnitine/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "carnitine-acetyl-l-carnitine" ;
  schema:name "Carnitine and acetyl-L-carnitine"@en ;
  schema:alternateName "L-carnitine"@en, "Acetyl-L-carnitine"@en, "ALCAR"@en ;
  schema:description "Acetyl-L-carnitine was tested to prevent nerve damage from chemotherapy and made it worse, with the extra damage still present two years later; guidelines advise against it. Plain L-carnitine for cancer fatigue has mixed results and guidelines do not recommend it either."@en ;
  schema:url <https://onco.cc/technologies/carnitine-acetyl-l-carnitine/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/carnitine> ;
  onco:status "negative" ;
  onco:tag "complementary", "supportive-care", "evidence:harm" ;
  onco:related <https://onco.cc/technologies/alpha-lipoic-acid/>, <https://onco.cc/technologies/creatine-supplements/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/nutrition-lifestyle/> ;
  onco:technologies <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/>, <https://onco.cc/technologies/cipn-recovery-and-treatment/>, <https://onco.cc/technologies/cancer-related-fatigue-management/> ;
  onco:drugs <https://onco.cc/drugs/vismodegib/> ;
  onco:terms <https://onco.cc/terms/peripheral-neuropathy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/> .